Reframing India's Approach to Snakebite Envenomation Through a One Health Approach
DOI:
https://doi.org/10.56450/JEFI.2026.v4i02.010Keywords:
Snake Bites, One Health, Public Health PolicyAbstract
Snakebite envenomation remains a neglected public health challenge in India. More than 1,000,000 snakebites occur annually, causing approximately 58,000 deaths,[2] and disability in nearly four times as many people.[1] The World Health Organization (WHO) has set a target of reducing snakebite-related deaths by 50% by 2030.[3] India has aligned its national response through the launch of the National Action Plan for Prevention and Control of Snakebite Envenoming (NAPSE) in 2024.[4] Achieving this goal, however, requires moving beyond a predominantly biomedical response to adopting a one-health framework which consider human, animal and environmental aspects of the problem together to find comprehensive solutions.
Downloads
References
1. Menon JC, Bharti OK, Aravind MS, Bawaskar HS, Mohapatra A, Punde D, et al. Cross-sectional survey of the incidence, mortality and socioeconomic burden of snakebite envenoming in India. Nat Commun. 2025;16(1):1-8 https://doi.org/10.1038/s41467-025-64849-2
2. Suraweera W, Warrell D, Whitaker R, Menon G, Rodrigues R, Fu SH, et al. Trends in snakebite deaths in India from 2000 to 2019 in a nationally representative mortality study. eLife. 2020;9:e54076. https://doi.org/10.7554/eLife.54076 . https://doi.org/10.7554/elife.54076
3. World Health Organization. Snakebite envenoming: A strategy for prevention and control. Geneva: WHO; 2019. Available from https://www.who.int/publications/i/item/9789241515641 (Accessed on 25 Jun 2026)
4. Ministry of Health and Family Welfare, Government of India. National Action Plan for Prevention and Control of Snakebite Envenoming (NAPSE): A strategic approach to halve the deaths and disabilities due to snakebite envenoming by 2030. New Delhi: Ministry of Health and Family Welfare, Government of India; 2024. Available from https://www.ncdc.mohfw.gov.in/uploads/pdf/COH9.pdf (Accessed on 25 Jun 2026). https://doi.org/10.4103/jfmpc.jfmpc_902_24
5. Senji Laxme RR, Khochare S, de Souza HF, et al. Beyond the "Big Four": Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies. PLoS Negl Trop Dis. 2019;13(12):e0007899. https://doi.org/10.1371/journal.pntd.0007899
6. Senji Laxme RR, Attarde S, Khochare S, et al. Biogeographical venom variation in the Indian spectacled cobra (Naja naja) underscores the pressing need for pan-India efficacious snakebite therapy. PLoS Negl Trop Dis. 2021;15(2):e0009150. https://doi.org/10.1371/journal.pntd.0009150
7. Gopal G, Muralidar S, Prakash D, et al. The concept of Big Four: Road map from snakebite epidemiology to antivenom efficacy. Int J Biol Macromol. 2023;242(Pt 1):124771. https://doi.org/10.1016/j.ijbiomac.2023.124771
8. Harrison RA, Hargreaves A, Wagstaff SC, Faragher B, Lalloo DG. Snake envenoming: a disease of poverty. PLoS Negl Trop Dis. 2009;3(12):e569. https://doi.org/10.1371/journal.pntd.0000569
9. Chakma JK, Menon JC, Dhaliwal RS, Indian Council of Medical Research. White paper on venomous snakebite in India. Indian J Med Res. 2020;152(6):568-74. https://doi.org/10.4103/ijmr.ijmr_3377_20
10. Ministry of Health & Family Welfare, Government of India. Standard Treatment Guidelines on the Management of Snake Bites. New Delhi: MoHFW; 2016. Available from https://nhm.gov.in/images/pdf/guidelines/nrhm-guidelines/stg/Snakebite_Full.pdf (Last Accessed on 25 Jun 2026)
11. Gutiérrez JM, Bolon I, Borri J, Ruiz de Castañeda R. Broadening the research landscape in the field of snakebite envenoming: Towards a holistic perspective. Toxicon. 2023;233:107279. https://doi.org/10.1016/j.toxicon.2023.107279
12. White J. Envenoming and antivenom use in Australia. Toxicon. 1998;36(11):1483–92. https://doi.org/10.1016/s0041-0101(98)00138-x
13. Babo Martins S, Bolon I, Alcoba G, et al. Assessment of the effect of snakebite on health and socioeconomic factors using a One Health perspective in the Terai region of Nepal: a cross-sectional study. Lancet Glob Health. 2022;10(3):e409–e415. https://doi.org/10.3998/mpub.12710084.cmp.5m60qw33k
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2026 Kinshuk Gupta, Rajesh Kumar (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
